Randomized Placebo‐Controlled Trial Assessing the Effect of 24‐Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME‐2 Trial

BACKGROUND: There is no drug therapy for abdominal aortic aneurysm (AAA). FAME‐2 (Fenofibrate in the Management of Abdominal Aortic Aneurysm 2) was a placebo‐controlled randomized trial designed to assess whether administration of 145 mg of fenofibrate/d for 24 weeks favorably modified circulating m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinchbeck, Jenna L., Moxon, Joseph V., Rowbotham, Sophie E., Bourke, Michael, Lazzaroni, Sharon, Morton, Susan K., Matthews, Evan O., Hendy, Kerolos, Jones, Rhondda E., Bourke, Bernie, Jaeggi, Rene, Favot, Danella, Quigley, Frank, Jenkins, Jason S., Reid, Christopher M., Velu, Ramesh, Golledge, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404864/
https://www.ncbi.nlm.nih.gov/pubmed/30371299
http://dx.doi.org/10.1161/JAHA.118.009866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404864/
https://www.ncbi.nlm.nih.gov/pubmed/30371299
http://dx.doi.org/10.1161/JAHA.118.009866

Ejemplares similares